MYD88 and Hepatic fibrosis: Similarly, MyD88−/−, but not TRIF−/−, mice demonstrated reduced fibrogenic gene expression at the early phase after BDL, whereas both MyD88−/− and TRIF−/− mice had reduced liver fibrosis at the late phase of liver fibrosis [10].